Tradestie Institutional Equity Comparison Engine

ZBIO vs COGT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZBIO Overall Edge

ZBIO Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zenas BioPharma, Inc. Common Stock (ZBIO) driven by superior Momentum & Technical, Options & Structure while COGT counters with relative strength in Growth & Margin. Fundamentally, ZBIO trades at N/M Forward P/E with -2747.5% operating margin (-100.0% YoY revenue) versus COGT at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, ZBIO sits in CONSOLIDATION (13th %ile IV; Dealer Gamma Walls on Pro) against COGT sits in BREAKDOWN (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ZBIO N/M vs COGT N/M Fwd P/E
Growth & Margin Winner COGT
Op Margin -2747.5% vs 0.0% ยท YoY -100.0% vs -100.0%
Momentum & Technical Winner ZBIO
1Y -21.7% vs -18.9% ยท 52W Pos 46% vs 1%
Options & Structure Winner ZBIO
CONSOLIDATION (13th %ile IV) vs BREAKDOWN (5th %ile IV)
ZBIO NASDAQ
Zenas BioPharma, Inc. Common Stock
Pharmaceutical Preparations
$27.93
-0.29% 1D
Market Cap $1.9B
1M Return +12.44%
1Y Return -21.68%
Forward P/E N/M
Unified AI Score
49.4 / 100 HOLD
Tech 44.0 Fund 53.0 Flow 69.0 Mom 50.0
COGT NASDAQ
Cogent Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$27.44
-3.92% 1D
Market Cap $5.0B
1M Return -7.05%
1Y Return -18.89%
Forward P/E N/M
Unified AI Score
42.7 / 100 HOLD
Tech 28.0 Fund 49.0 Flow 69.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZBIO -21.68% COGT -18.89% Spread: +2.79 pp (COGT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ZBIO Revenue COGT Revenue ZBIO Op. Margin COGT Op. Margin Margin Edge
FY2017 N/A $10M N/A -312.8% COGT
FY2018 N/A $10M N/A -369.9% COGT
FY2019 N/A $20M N/A -143.0% COGT
FY2020 N/A $10M N/A -1044.3% COGT
FY2023 $50M N/A -74.3% N/A ZBIO
FY2024 $10M N/A -3277.8% N/A ZBIO
FY2025 $10M N/A -3830.6% N/A ZBIO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZBIO (3) vs COGT (3)
Institutional Metric ZBIO COGT Criterion Row Winner
Market Capitalization Scale $1.9B $5.0B Larger Scale COGT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% -100.0% Higher Growth Tie
Operating Margin (TTM) Profitability -2747.5% 0.0% Higher Margin COGT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -265.1% -99.6% Higher ROE COGT
52-Week Range Position Momentum 46% ($14โ€“$45) 1% ($27โ€“$44) Stronger Trend ZBIO
Beta / 30D Volatility Risk Regime 1.16ฮฒ ยท 59% Vol 1.46ฮฒ ยท 61% Vol Lower Realized Risk ZBIO
Unified Institutional Score Composite Signal 49.4 / 100 (HOLD) 42.7 / 100 (HOLD) Higher Composite ZBIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZBIO vs COGT Buy Guide
ZBIO CONSOLIDATION
58d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 13th %ile
IV Regime Compressed (<25th %ile)
Live ZBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
COGT BREAKDOWN
73d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live COGT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZBIO nor COGT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.